IBM Watson Health | Pharmacy Talk
Demystifying the use of AI in Pharmacy
How the use and training of AI-based medication management will impact hospital pharmacy. IBM Micromedex with Watson combines evidence-based drug content with advanced AI search capabilities to deliver rapid, reliable answers at the point of care. Improve care experiences and efficiency with insights into drug selection, dosing, toxicology and IV compatibility – accessible from your EHR, computer or mobile device.
- Primer, 101 for AI in Pharmacy – terminology, examples in med use process
- Augmented intelligence vs. Artificial intelligence, leveraging the strengths of computers and clinicians together to obtain improved outcomes for patients
- Why should you know this area? Domain expert and contribute as a translator, clinical voice in the room
- Hierarchy of AI from AI to Deep Learning
- Critical components of high-fidelity AI – volume of data, algorithms-built w/out confirmational bias, recurring opportunities for evolution, training the models, et.
About IBM® Micromedex® with Watson™
IBM® Micromedex® with Watson™ combines evidence-based drug content with advanced AI search capabilities to deliver rapid, reliable answers at the point of care.
Whitley Yi, PharmD, BCPS: Pharmacy Specialist, Digital Health Clinical Operations, Well, Co-Founder, AI Collective, Lecturer, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Scott Nelson, PharmD, MS, CPHIMS, FAMIA, Program Director, MS Applied Clinical Informatics (MSACI), Assistant Professor, Biomedical Informatics, Assistant Clinical Director, HealthIT, Vanderbilt University Medical Center
Arti Bhavsar, PharmD, Clinical Program Director, IBM Watson Health
Drug Shortage Management and Supply Chain Solutions
Join the Pharmacy Podcast Network and IBM Watson Health for another podcast, episode 2 in the 4 part series, focused on how to improve efficiencies across your organizations’ drug shortage management and supply chain. Listen to three experts discuss:
- Drug shortage management and prevention – from classification and communication to key stakeholders to how COVID-19 has impacted hospital drug shortages
- The role of technology & data in assisting pharmacists in solving these inventory and management challenges
- How automation and emerging technology can help pharmacists provide the best care for their patients
OrbitalRX, now with IBM Micromedex, combines real-time inventory awareness and clinical decision support capabilities to help hospital pharmacies proactively manage drug shortages and efficiently identify effective alternatives. View the latest evidence-based treatment information, check your hospital’s current drug inventory status, and provide purchasers with a consolidated view of procurement options – all within a single solution.
Learn more here: https://www.ibm.com/
- Nate Peaty, PharmD, MS, Chief Strategy Officer and Co-founder | OrbitalRX
- Brian Spoelhof, PharmD, Assistant Manager of Pharmacy – Medication Utilization Strategy | University of Virginia
- Chris Virgilio, PharmD, BCPS Clinical Program Director, Micromedex | IBM Watson Health
Enhance Care Decision Making with Evidence & AI
In many ways, AI has been applied in medicine, such as in drug development, business intelligence and patient care. It has also been applied to clinical decision support tools – where it can help rapidly surface insights from vast libraries of biomedical information to facilitate fast, informed decisions.
For clinicians to be comfortable with AI in supporting decision making, trust is essential. Trust can be influenced by several human factors, such as user education, past experiences, user biases and perception towards automation, as well as properties and the reliability of the technology itself.1 However, nothing builds trust like results. Over the past two decades of AI use in healthcare, a body of evidence is emerging on how AI can help in areas such as clinical decision support.
Alan Ehrlich, Executive Editor at DynaMed and an Associate Professor in Family Medicine at the University of Massachusetts Medical School in Worcester
Bio: Alan Ehrlich, MD, FAAFP is the Executive Editor at DynaMed and an Associate Professor in Family Medicine at the University of Massachusetts Medical School in Worcester. He is board certified from the American Board of Family Medicine and a Fellow of the American Academy of Family Physicians. Alan graduated from Rutgers New Jersey Medical School in 1984 and completed his residency at the University of Massachusetts Medical Center in 1987. He is involved in the teaching of Evidence-Based Medicine to third year medical students and writes the Evidence-Based Medicine column for Clinical Advisor magazine.
Eileen Yoshida, Deputy Editor of Medication and Clinical Informatics, EBSCO Health
Bio: Eileen Yoshida is the Deputy Editor of Medication and Clinical Informatics at EBSCO Health. In this role, she leads the medication and clinical informatics strategies for the organization. Eileen brings over 25 years of experience in the healthcare industry, most recently leading the Clinical Knowledge Management and Decision Support team at Partners HealthCare. Previously, she served with Capgemini as an EHR implementation strategist and with the University of Chicago Hospitals in a special project’s role. Eileen has extensive experience in clinical informatics, EHR implementation, healthcare consulting and clinical pharmacy and is a published author and speaker on clinical decision support. She holds a degree in Pharmacy from the University of Toronto and a master’s in business administration from the Kellogg School of Management at Northwestern University.
Report from HIMSS19: Novel Techniques to Combat the Opioid Misuse Epidemic
Courtney Holmes, RN, Executive Clinical Consultant, IBM Watson Health
Bio: Courtney Holmes is a Clinical Program Director supporting IBM’s Micromedex solution suite, as well as an Executive Clinical Consultant with Watson Health. Courtney focuses on providing clinical leadership in the sales and development of cognitive solutions and engagement with key stakeholders to support meaningful use of Watson Health solutions. She provides subject matter expertise for the Healthcare. Provider Segment. This includes providing strategic and clinical expertise to ensure high value development/improvements and intuitive, seamless clinical workflow design.
Blog post: https://www.ibm.com/blogs/